Gorman Brian 4
4 · OPIANT PHARMACEUTICALS, INC. · Filed Jan 5, 2023
Insider Transaction Report
Form 4
Gorman Brian
Other
Transactions
- Sale
Common Stock
2023-01-05$20.20/sh−1,313$26,523→ 32,434 total
Footnotes (1)
- [F1]These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.